Accelerating drug discovery targeting KRAS mutations with advanced high-throughput hit identification technologies
Current Molecular Pharmacology · 2026 · 19 (1) · 225-227
DOI: 10.1016/j.cmp.2026.09.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Molecular Pharmacology, 2026. Verfasst von Hua Zhang und 2 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhang, H., Zhang, L., & Liu, C. (2026). Accelerating drug discovery targeting KRAS mutations with advanced high-throughput hit identification technologies. Current Molecular Pharmacology, 19(1), 225-227. https://doi.org/10.1016/j.cmp.2026.09.002
Vancouver
Zhang H, Zhang L, Liu C. Accelerating drug discovery targeting KRAS mutations with advanced high-throughput hit identification technologies. Current Molecular Pharmacology. 2026;19(1):225-227. doi:10.1016/j.cmp.2026.09.002
BibTeX
@article{Zhang2026,
author = {Zhang, Hua and Zhang, Liwen and Liu, Chang},
title = {Accelerating drug discovery targeting KRAS mutations with advanced high-throughput hit identification technologies},
journal = {Current Molecular Pharmacology},
year = {2026},
volume = {19},
number = {1},
pages = {225--227},
doi = {10.1016/j.cmp.2026.09.002}
}
EUVIMED